A citation-based method for searching scientific literature

Shu-Lei Liu, Chong Wang, Teng Jiang, Lan Tan, Ang Xing, Jin-Tai Yu. Mol Neurobiol 2016
Times Cited: 97







List of co-cited articles
1115 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
G N Patrick, L Zukerberg, M Nikolic, S de la Monte, P Dikkes, L H Tsai. Nature 1999
17

Physiological and pathological phosphorylation of tau by Cdk5.
Taeko Kimura, Koichi Ishiguro, Shin-Ichi Hisanaga. Front Mol Neurosci 2014
119
12

Neurotoxicity induces cleavage of p35 to p25 by calpain.
M S Lee, Y T Kwon, M Li, J Peng, R M Friedlander, L H Tsai. Nature 2000
824
12

The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
11

Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
Varsha Shukla, Susan Skuntz, Harish C Pant. Arch Med Res 2012
104
10

Cyclin-dependent kinases in brain development and disease.
Susan C Su, Li-Huei Tsai. Annu Rev Cell Dev Biol 2011
230
10

A decade of CDK5.
R Dhavan, L H Tsai. Nat Rev Mol Cell Biol 2001
866
10

Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses.
Anna Wilkaniec, Grzegorz A Czapski, Agata Adamczyk. J Neurochem 2016
32
28


Alzheimer's disease.
Philip Scheltens, Kaj Blennow, Monique M B Breteler, Bart de Strooper, Giovanni B Frisoni, Stephen Salloway, Wiesje Maria Van der Flier. Lancet 2016
8


Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice.
Diego Piedrahita, Israel Hernández, Alejandro López-Tobón, Dmitry Fedorov, Boguslaw Obara, B S Manjunath, Ryan L Boudreau, Beverly Davidson, Frank Laferla, Juan Carlos Gallego-Gómez,[...]. J Neurosci 2010
118
8

Tau and neurodegenerative disease: the story so far.
Khalid Iqbal, Fei Liu, Cheng-Xin Gong. Nat Rev Neurol 2016
374
8

Neuroprotective Mechanisms Mediated by CDK5 Inhibition.
Gohar Mushtaq, Nigel H Greig, Firoz Anwar, Fahad A Al-Abbasi, Mazin A Zamzami, Hasan A Al-Talhi, Mohammad A Kamal. Curr Pharm Des 2016
35
22

p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.
L H Tsai, I Delalle, V S Caviness, T Chae, E Harlow. Nature 1994
787
8

Cdk5: multitasking between physiological and pathological conditions.
Joao P Lopes, Paula Agostinho. Prog Neurobiol 2011
83
9

Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5.
Feng Liu, Yuan Su, Baolin Li, Yan Zhou, John Ryder, Patricia Gonzalez-DeWhitt, Patrick C May, Binhui Ni. FEBS Lett 2003
79
10

Cyclin dependent kinase 5: A novel avenue for Alzheimer's disease.
Anisha S Bhounsule, Lokesh Kumar Bhatt, Kedar S Prabhavalkar, Manisha Oza. Brain Res Bull 2017
24
33

Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
Jinsoo Seo, Oleg Kritskiy, L Ashley Watson, Scarlett J Barker, Dilip Dey, Waseem K Raja, Yuan-Ta Lin, Tak Ko, Sukhee Cho, Jay Penney,[...]. J Neurosci 2017
73
10

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
R Vassar, B D Bennett, S Babu-Khan, S Kahn, E A Mendiaz, P Denis, D B Teplow, S Ross, P Amarante, R Loeloff,[...]. Science 1999
7


Amyloid precursor protein processing and Alzheimer's disease.
Richard J O'Brien, Philip C Wong. Annu Rev Neurosci 2011
831
7

p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Wenqi Li, Megan E Allen, Yanfang Rui, Li Ku, Guanglu Liu, Andrew N Bankston, James Q Zheng, Yue Feng. J Neurosci 2016
17
41


Cdk5: a multifaceted kinase in neurodegenerative diseases.
Zelda H Cheung, Nancy Y Ip. Trends Cell Biol 2012
149
7

Neuronal cell cycle: the neuron itself and its circumstances.
José M Frade, María C Ovejero-Benito. Cell Cycle 2015
108
7

Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.
Jeyapriya Raja Sundaram, Charlene Priscilla Poore, Noor Hazim Bin Sulaimee, Tej Pareek, A B M A Asad, Ramamoorthy Rajkumar, Wei Fun Cheong, Markus R Wenk, Gavin Stewart Dawe, Kai-Hsiang Chuang,[...]. J Neurosci 2013
55
12

Tau in physiology and pathology.
Yipeng Wang, Eckhard Mandelkow. Nat Rev Neurosci 2016
761
7

Tau protein kinases: involvement in Alzheimer's disease.
Ludovic Martin, Xenia Latypova, Cornelia M Wilson, Amandine Magnaudeix, Marie-Laure Perrin, Catherine Yardin, Faraj Terro. Ageing Res Rev 2013
286
7

A phase II trial of tideglusib in Alzheimer's disease.
Simon Lovestone, Mercè Boada, Bruno Dubois, Michael Hüll, Juha O Rinne, Hans-Jürgen Huppertz, Miguel Calero, María V Andrés, Belén Gómez-Carrillo, Teresa León,[...]. J Alzheimers Dis 2015
224
7

Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
Joao P Lopes, Catarina R Oliveira, Paula Agostinho. Aging Cell 2010
69
10

Biological functions of CDK5 and potential CDK5 targeted clinical treatments.
Alison Shupp, Mathew C Casimiro, Richard G Pestell. Oncotarget 2017
46
15

Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease.
Kai-Hui Sun, Yolanda de Pablo, Fabien Vincent, Emmanuel O Johnson, Angela K Chavers, Kavita Shah. Mol Biol Cell 2008
71
8

Aβ-induced Golgi fragmentation in Alzheimer's disease enhances Aβ production.
Gunjan Joshi, Youjian Chi, Zheping Huang, Yanzhuang Wang. Proc Natl Acad Sci U S A 2014
80
7

Cdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology.
Yanghui Sheng, Lei Zhang, Susan C Su, Li-Huei Tsai, J Julius Zhu. Cereb Cortex 2016
18
33

APP processing in Alzheimer's disease.
Yun-wu Zhang, Robert Thompson, Han Zhang, Huaxi Xu. Mol Brain 2011
412
6

Cdk5 activity in the brain - multiple paths of regulation.
Kavita Shah, Debomoy K Lahiri. J Cell Sci 2014
105
6

Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.
Jonathan C Cruz, Huang-Chun Tseng, Joseph A Goldman, Heather Shih, Li-Huei Tsai. Neuron 2003
438
6


Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration.
Jeyapriya R Sundaram, Elizabeth S Chan, Charlene P Poore, Tej K Pareek, Wei Fun Cheong, Guanghou Shui, Ning Tang, Chian-Ming Low, Markus R Wenk, Sashi Kesavapany. J Neurosci 2012
75
8

Cdk5 is a key factor in tau aggregation and tangle formation in vivo.
Wendy Noble, Vicki Olm, Kazuyuki Takata, Evelyn Casey, O Mary, Jordana Meyerson, Kate Gaynor, John LaFrancois, Lili Wang, Takayuki Kondo,[...]. Neuron 2003
365
6


Structure and regulation of the CDK5-p25(nck5a) complex.
C Tarricone, R Dhavan, J Peng, L B Areces, L H Tsai, A Musacchio. Mol Cell 2001
196
6

The Emerging Role of Cdk5 in Cancer.
Karine Pozo, James A Bibb. Trends Cancer 2016
66
9

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
L Meijer, A Borgne, O Mulner, J P Chong, J J Blow, N Inagaki, M Inagaki, J G Delcros, J P Moulinoux. Eur J Biochem 1997
6

Alzheimer's disease.
Colin L Masters, Randall Bateman, Kaj Blennow, Christopher C Rowe, Reisa A Sperling, Jeffrey L Cummings. Nat Rev Dis Primers 2015
585
6

Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5.
Fu-Ning Hsu, Mei-Chih Chen, Ming-Ching Chiang, Eugene Lin, Yueh-Tsung Lee, Pao-Hsuan Huang, Guan-Shun Lee, Ho Lin. J Biol Chem 2011
71
7

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.
Shichun Tu, Shu-ichi Okamoto, Stuart A Lipton, Huaxi Xu. Mol Neurodegener 2014
275
5

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease.
Ramon Yarza, Silvia Vela, Maite Solas, Maria J Ramirez. Front Pharmacol 2016
162
5

Neuropathological alterations in Alzheimer disease.
Alberto Serrano-Pozo, Matthew P Frosch, Eliezer Masliah, Bradley T Hyman. Cold Spring Harb Perspect Med 2011
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.